Ulf WIInberg - Jul 18, 2022 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Stock symbol
INKT
Transactions as of
Jul 18, 2022
Transactions value $
$27,646
Form type
4
Date filed
7/21/2022, 03:21 PM
Previous filing
Jul 6, 2022
Next filing
Sep 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Purchase $4.44K +3.34K +1.2% $1.33 282K Jul 18, 2022 Direct F1
transaction INKT Common Stock Purchase $23.2K +16.7K +5.92% $1.39 298K Jul 19, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.31 - $1.44. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
F2 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.37 - $1.51. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.